Last reviewed · How we verify

NCT07137169

LIMA Protocol Towards Palatal Fistula and Maxillary Growth in Cleft Palate

Completed NA Last updated 22 August 2025
What this trial tests

NA trial testing LIMA protocol in Cleft Palate in 35 participants. Completed in 31 December 2024.

Timeline
1 January 2022
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorIndonesia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment35
Start date1 January 2022
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

Adults 9 Months to 24 Months, any sex, with Cleft Palate or Fistula of Soft Palate (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial compared palatoplasty outcomes using the LIMA protocol (Hybrid and one-flap techniques) versus the RSCM protocol (two-flap technique) in patients with unilateral Veau III-IV cleft palate at Cipto Mangunkusumo Hospital from January 2022 to December 2024.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cleft Palate

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07137169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing